1 | 1.2范围-药品研发 | Manufacture of investigationalproducts |
2 | 3.2.3变更管理系统 | There is generally a difference in formality ofchange management processes prior to the initial regulatory submission andafter submission, where changes to the regulatory filing might be requiredunder regional requirements. |
3 | 3.2.3变更管理系统(b) | Proposed changes should beevaluated relative to the marketing authorisation, including design space,where established, and/or current product and process understanding. Thereshould be an assessment to determine whether a change to the regulatory filingis required under regional requirements. |
4 | 3.2.3变更管理系统(c) | Prospective evaluation criteria for a proposed changeshould be set |
5 | 3.2.4工艺性能和产品质量的管理回顾(b)-(2) | Provision, training and/or realignment of resources; |
6 | 5.术语-设计空间 | The multidimensional combination and interaction of input variables (e.g., material attributes) and process parameters that have been demonstrated to provide assurance of quality. |